Observational Study of Allergic Rhinitis in Children

Launched by ALK-ABELLÓ A/S · Dec 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how allergic rhinitis, a common condition that causes sneezing, runny nose, and itchy eyes, is managed in children. Researchers want to understand the different ways that pediatricians in France treat this condition, focusing on children under 18 years old who have been diagnosed with allergic rhinitis. The study is currently looking for participants, and it includes children from about 2 to 17 years old. If a child has allergic rhinitis and their parents agree to let them participate, they may be eligible for the study.

Parents can expect that their child's involvement will include providing information about their child's condition and treatment. It’s important to note that children who do not want to participate or share their personal information will not be included in the study. Overall, this research aims to improve our understanding of how allergic rhinitis is treated in young patients, which could lead to better care and outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Under 18 years of age
• • With allergic rhinitis
• • Who's representative of the parental authority did not object to his child's participation after oral and written information and who agrees to participate
• Exclusion Criteria:
• • Child or adolescent opposed to participate or collect his personal data